SPEAKER_04

It was called clear cell renal cell carcinoma.

But, you know, so...

surveying the body and these companies that are out there right now which do it, I think are really important.

Because even if you are young and you have no suspicion you're going to have cancer, having that baseline against which you can compare later changes is important.

Because I could do, for instance, a CT scan or an MRI of you, and I'd find lots of little anomalies.

And they're generally in the field called phantomas.

There are these objects that may be worrisome, but we won't know that they're worrisome.

And certainly, I could do a biopsy of them and poke a needle into your chest to pick out a piece of it.

But if I come back six months and it's changed, then maybe it's something we need to go after more seriously.

So getting those kinds of regular scans, I think, is probably one of the more important things that could be done, but not by a CT scan.

Yeah, but maybe, for instance, there'd be a way to treat someone with a drug ahead of time that would minimize the effect of the CT scan.

Right?

Because the CT scans are generally causing oxidative damage.

And so if you could provide a local antioxidant, and I'm not saying that something like this exists.

It's a bit of a naive statement.

But if you could do that locally to the area that's being imaged or to the whole body, then maybe CT scans could be lessened in their problematic outcomes.

Yeah.

Well, it's interesting because what's happening with x-rays or CT scans is a fast forward of the kind of random damage that causes cancer in the first place.

And so because it's random, let me kind of go back a little bit as to why does cancer happen in the first place.

So let's go way back in evolution to the first time that there were single cells versus the first time that two cells met each other and said it was better to